ArticleThe Journal of international medical research2025
Triglyceride levels and 12-month outcomes in patients with intracerebral hemorrhage.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThe association between serum lipid levels and clinical outcomes following intracerebral hemorrhage remains unclear.MethodsData from consecutive patients hospitalized with intracerebral hemorrhage were prospectively collected between May 2005 and May 2018 and retrospectively analyzed. We documented the participants' baseline characteristics, clinical features, risk factors, routine laboratory test results, and outcomes at 12 months post-intracerebral hemorrhage.ResultsA total of 1450 patients with intracerebral hemorrhage were included in the final analysis. In the unadjusted model, triglyceride levels were negatively associated with the risk of poor outcomes when analyzed as a continuous variable (odds ratio, 0.83; 95% confidence interval: 0.73-0.94; P = 0.005) and a categorical variable (comparing levels above the median vs. below the median; odds ratio, 0.658; 95% confidence interval: 0.532-0.820; P < 0.001). Consistent results were observed in the fully adjusted model: triglyceride levels remained significantly negatively associated with unfavorable outcomes (continuous variable: odds ratio, 0.87; 95% confidence interval: 0.760-0.999; P = 0.049 and quartile-based categorical variable: odds ratio, 0.699; 95% confidence interval: 0.546-0.893; P = 0.005). Restricted cubic spline analysis revealed linear and nonlinear relationships between triglyceride levels and outcomes (P for linearity = 0.0005 and P for nonlinearity = 0.0075), with the most pronounced trend observed in patients aged 70-100 years.ConclusionsLow admission triglyceride levels are an independent predictor of poor 12-month outcomes in patients with intracerebral hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.